Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVZO-023 in Advanced Solid Tumors and Breast Cancer
NCT06998407Phase 2Recruiting
- Sponsor
- Avenzo Therapeutics
- Start
- Aug 2025
- Primary completion
- Aug 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of AVZO-023 in breast cancer, solid tumor, sponsored by Avenzo Therapeutics. Started Aug 2025; status: recruiting.
02
Drugs
AVZO-023
03
Conditions
breast cancersolid tumor
Beyond the preview
Go deeper on NCT06998407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06998407.